HealingMaps Take: Dr. Aziz offers the most expansive peptide menu in New York City with over 25 compounds. He regularly teaches peptide seminars to other physicians, positioning him as a thought leader rather than just a prescriber. The named stacks (Wolverine, Glow) and rare compounds like Cerebrolysin are not found at most competing clinics.
Dr. Michael Aziz, MD offers 19 specific peptide compounds (BPC-157, CJC-1295, Ipamorelin, Sermorelin, Tesamorelin, Semaglutide, and 13 more), placing it the deepest disclosed menu of any of the 20+ New York peptide clinics in our directory. The clinic is physician-led (MD or DO); about half of New York peptide clinics in our directory are.
✓ Last verified: April 14, 2026 — Edited & verified by Angelica Bottaro for HealingMaps Editorial Staff
| Review Scores | Practice site: 4.86 (83 reviews); Yelp: 27 reviews |
| Location | New York City, New York |
| Address | 515 Madison Ave, Suite 602, New York, NY 10022 |
| Phone | (212) 906-9111 |
| Website | michaelazizmd.com |
| Treatments | BPC-157, Sermorelin, Ipamorelin, Tesamorelin, CJC-1295, GHRP-2, GHK-Cu, Thymosin Beta-4, Thymosin Alpha-1, Cerebrolysin, Epithalon, Semaglutide, Tirzepatide, Retatrutide, PT-141, Selank, Semax, Dihexa, SS-31, MOTS-C, KPV |
| Conditions Treated | ADHD, skin aging, weight loss, IBS, low energy, ED, post-surgical recovery, Alzheimer’s, Lyme disease, fibromyalgia, joint pain, chronic inflammation |
| Administration | Subcutaneous injection, Transdermal cream, Nasal spray, Oral tablet |
| Cost | N/A |
| Insurance | Referenced; consultation required |
| Clinical Lead | Michael Aziz, M.D. — Board certified internal medicine, attending at Lenox Hill Hospital, Albert Einstein College of Medicine |
Your prescribing provider, Dr. Michael Aziz, is verified in the federal CMS National Plan & Provider Enumeration System (NPPES) under NPI 1619067998, with a primary specialty of Internal Medicine and a primary practice address in New York, NY. CMS records show this NPI has been active since 2006. NPPES record verified 2026-05-08. Dr. Michael Aziz’s NPI tenure is longer-tenured than most of the 9 New York peptide providers we’ve verified in NPPES (longest-tenured peer registered in 2006; cohort median 2008).
What this means for you: In the US, any actively state-licensed physician can legally prescribe compounded peptides — board certification in a specific specialty isn’t required for peptide prescriptions. Internal Medicine training focuses on chronic-disease and metabolic care that aligns with GLP-1 weight-loss and longevity peptide protocols.
National peptide therapy pricing — based on 487 verified peptide clinics in our directory (April 2026 data). Adjust the calculator below to model your own protocol.
Most Dr. Michael Aziz, MD patients report the consult-to-first-injection window runs 1–3 weeks depending on lab turnaround and pharmacy fulfillment.
The questions below are pulled from the gaps in this specific listing — areas the clinic doesn’t publicly answer that you should clarify before booking. Each one is designed to get you a useful answer in 30 seconds or less.
“Dr. Aziz is one of the few physicians in NYC who truly understands the full spectrum of peptide therapy. His Wolverine stack changed my recovery timeline completely. — Practice Review”
Dr. Michael Aziz is a board certified internist and attending physician at Lenox Hill Hospital in Manhattan. He trained at Albert Einstein College of Medicine and has built one of the most comprehensive peptide programs in New York City with over 25 compounds. He maintains offices on Madison Avenue in Midtown and in the Hamptons. Dr. Aziz frequently teaches peptide therapy seminars to other physicians and offers named protocol stacks including the Wolverine Pack and Glow stack.
For more on how peptide therapy works, see our guide to peptide therapy.
Patients value the breadth of the peptide menu and Dr. Aziz’s willingness to prescribe compounds that most clinics do not carry. The teaching background adds clinical credibility. Multiple delivery methods accommodate different preferences.
Reviews are mixed across platforms, with a 3.2 on RateMDs alongside the 4.86 on the practice site. Pricing is not published online.
Schedule a consultation through the website or by phone. Dr. Aziz evaluates health history and goals before designing a protocol from the 25+ compound menu.
Explore more vetted peptide therapy clinics near you in our nationwide directory.
Learn more about this treatment:
Looking for more BPC-157 providers? Browse our directory of BPC-157 and recovery peptide clinics — including options in New York across the United States.
Based on this listing, Dr. Michael Aziz, MD names 19 specific peptide compounds: BPC-157, CJC-1295, Ipamorelin, Sermorelin, Tesamorelin, Semaglutide, and 13 more. The clinic may offer additional compounds not published on its public listing — confirm the full menu on a consult call.
Yes. Dr. Michael Aziz is registered in the federal CMS National Plan & Provider Enumeration System (NPPES) under NPI 1619067998, with a primary specialty of Internal Medicine and a primary practice address in New York, NY. The NPI has been active since 2006.
Dr. Michael Aziz, MD doesn’t mention telehealth or virtual visits on its listing. Most peptide clinics require in-person evaluation for the initial consult; some offer virtual follow-ups once a patient is stable. If geography or travel matters to you, ask on the consult call whether they can prescribe and follow up virtually — and which states they’re licensed to do so in.
Among verified New York peptide clinics in the HealingMaps directory, Dr. Michael Aziz, MD ranks the deepest disclosed peptide menu of any New York clinic in the directory. Compound depth is one signal among several — provider credentials, pharmacy sourcing transparency, and lab requirements also matter when comparing.
Dr. Michael Aziz, MD is located in New York, New York. The full street address, phone number, and hours are listed in the data card above.
Themes drawn from HealingMaps editorial analysis of verified New York peptide clinics in our directory. Refreshed quarterly; percentages rounded to nearest 5%.
Across New York peptide clinics in our directory, BPC-157 appears in 65% of listings; CJC-1295 in 55%; Ipamorelin in 50%; Sermorelin in 40%. Compounds appearing in fewer than 20% of New York listings — including Semaglutide, Semax, Selank — are less commonly disclosed; patients seeking those should specifically ask whether the clinic prescribes them.
15% of New York clinics in our directory openly state whether they use a 503A or 503B compounding pharmacy. The rest leave the class unstated. The distinction matters for patients — 503A pharmacies fill prescriptions individually after your provider writes them (typically a few-day wait, in-state shipping), while 503B outsourcing facilities pre-batch under direct FDA inspection (often supporting same-visit fulfillment and direct-to-home shipping). Worth asking specifically before you book.
50% of verified New York clinics name an MD or DO as clinical lead (this listing’s clinical lead is Internal Medicine-trained). The remainder are NP/PA-led or don’t publicly name a specific prescribing clinician. Any state-licensed physician, NP, or PA can legitimately prescribe compounded peptides — but knowing your prescriber’s training and tenure helps you assess fit for your specific protocol.
The median New York clinic in our directory publishes 6 specific peptide compounds on its listing. The deepest disclosed menu names 19; 10% of listings name no specific compounds at all. A wide menu means more options at one clinic; a narrow menu can reflect specialization (e.g. weight-loss-only programs) or limited public disclosure (the clinic prescribes more than it advertises).
Pharmacy sourcing: This clinic doesn’t state its 503A or 503B compounding pharmacy partner. The class affects how your prescription is fulfilled — custom-compounded with in-state shipping (503A) versus pre-batched with broader shipping including direct-to-home delivery (503B) — so it’s worth asking before starting any compounded protocol.
Verified prescriber on the public record at Dr. Michael Aziz, MD — NPI lookup confirms in CMS NPPES. The clinic’s menu publishes 19 compounds (BPC-157, CJC-1295, and Ipamorelin lead the list). The one piece missing publicly is pharmacy class disclosure (503A vs 503B); ask the clinic directly. See our full vetting rubric →
Leave a Reply